An Official Website of the United States Government
Company Information:
Name:
TROPHOGEN, INC.
Address:
TROPHOGEN, INC.
9714 Medical Center Dr.
ROCKVILLE, MD 20850-
9714 Medical Center Dr.
ROCKVILLE, MD 20850-
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Development of Superactive Analogs of LH and FSH
Award Year / Program / Phase:
2004 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Bruce D. Weintraub
Award Amount:
$100,000.00
Abstract:
DESCRIPTION (provided by applicant): Our previous structure-function studies resulted in the development of the first analogs of glycoprotein hormones with major increases in receptor binding affinity and bioactivity ("super active analogs"). More recently, we have further optimized human… More
Development of Novel VEGF Analogs
Award Year / Program / Phase:
2005 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Mariusz W. Szkudlinski
Award Amount:
$108,000.00
Abstract:
DESCRIPTION (provided by applicant): Our previous structure-function studies resulted in the development of the first analogs of glycoprotein hormones with major increases in receptor binding and bioactivity ("super-active analogs"). The majority of cancers are highly dependent on vascular… More
Development of Superactive Analogs of FSH
Award Year / Program / Phase:
2006 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Bruce D. Weintraub
Award Amount:
$1,217,268.00
Abstract:
DESCRIPTION (provided by applicant): Infertility affects about 10% of American couples, and there is a very large and rapidly growing market for therapeutics in this field, particularly the primary hormone responsible for ovarian oocyte development, follicle-stimulating hormone (FSH). Although… More
Development of Superagonist Analogs of Recombinant Human TSH
Award Year / Program / Phase:
2006 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Bruce D. Weintraub
Award Amount:
$101,500.00
Abstract:
DESCRIPTION (provided by applicant): Thyroid cancer is the most common malignancy of endocrine tissues and most patients require lifelong surveillance with diagnostic thyroid-stimulating hormone (TSH)-stimulated radioiodine uptake as well as remnant or metastatic ablation with radioidine therapy.… More
Recombinant Human TSH Superagonists for Imaging of Thyroid Cancer
Award Year / Program / Phase:
2006 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Bruce D. Weintraub
Award Amount:
$478,846.00
Abstract:
DESCRIPTION (provided by applicant): Thyroid cancer is the most common malignancy of endocrine tissues and most patients require lifelong surveillance with diagnostic thyroid-stimulating hormone (TSH)- stimulated radio-iodine imaging as well as remnant or metastatic ablation with radioiodine… More
Development of Superagonist Analogs of Recombinant Human TSH for Imaging and Ther
Award Year / Program / Phase:
2008 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Award Amount:
$1,774,735.00
Abstract:
DESCRIPTION (provided by applicant): Thyroid cancer is increasingly prevalent and the most common malignancy of endocrine tissues, and most patients require lifelong surveillance with diagnostic thyroid-stimulating hormone (TSH)-stimulated radioiodine upta
ke as well as thyroid remnant or tumor… More
Recombinant Human TSH Superagonists for Imaging of Thyroid Cancer
Award Year / Program / Phase:
2010 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Bruce D. Weintraub
Award Amount:
$1,739,909.00
Abstract:
DESCRIPTION (provided by applicant): Thyroid cancer is increasingly prevalent and the most common malignancy of endocrine tissues, and most patients require lifelong surveillance with diagnostic thyroid-stimulating hormone (TSH)-stimulated radioiodine upta
ke as well as thyroid remnant or tumor… More
Development of Superactive Analogs of FSH for Human Infertility
Award Year / Program / Phase:
2011 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Bruce D. Weintraub – 301-838-1936
Award Amount:
$2,931,156.00
Abstract:
DESCRIPTION (provided by applicant): Infertility affects about 10% of American couples, and there is a very large and rapidly growing market for therapeutics in this field, particularly the primary hormone responsible for ovarian oocyte development, human(h) follicle-stimulating hormone (FSH).… More
Novel High Affinity and Long-Acting Bovine FSH Analogs for Veterinary Superovulat
Award Year / Program / Phase:
2012 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Bruce D. Weintraub – 301-838-1936
Award Amount:
$150,000.00
Abstract:
DESCRIPTION (provided by applicant): Bovine ovarian superovulation is the current state-of-the-art method employed worldwide to maintain and improve milk and beef production through genetic selection of the best quality breeders and best quality embryos for transfer. These embryos may either be… More